Advaxis, Inc. announced that Gregory T. Mayes, Executive Vice President and Chief Business Officer, has resigned from the company in order to pursue a business opportunity focused on the development of a treatment for epileptic seizures, a condition that affects an immediate family member. The resignation will be effective as of December 30, 2016. Mr. Mayes will continue to serve as a Director on the company’s Board of Directors. The company is also announced the promotion of Sara Bonstein, the company’s Chief Financial Officer, to Executive Vice President. The promotion will be effective as of December 30, 2016.